Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma

Irish Journal of Medical Science

Volumn 182, Issue 4, 2013, Pages 621-627

  Zhang, W B ^a   Pan, Z Q ^a   Yang, Q S ^a   Zheng, X M ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Kidney cancer; microRNA; Migration; miR 509 5p; Renal cell carcinoma

Indexed keywords

MICRORNA; MICRORNA 509 5P; UNCLASSIFIED DRUG; MIRN509 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RENAL CELL CARCINOMA; UPREGULATION; WOUND HEALING ASSAY; ADOLESCENT; BLOOD; CELL MOTION; CHILD; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; INFANT; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; TUMOR CELL LINE; TUMOR INVASION; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 85027937281     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-013-0941-y     Document Type: Article

References (28)

1. Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373:1119–1132
2. Slaby O, Svoboda M, Michalek J, Vyzula R (2009) DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma. Klin Onkol 22:202–209
3. Kovacs G (1996) Molecular genetics of human renal cell tumours. Nephrol Dial Transpl 11(Suppl 6):62–65
4. Wang GK, Zhu JQ, Zhang JT et al (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659–666
5. Caporali A, Meloni M, Vollenkle C et al (2011) Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123:282–291
6. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in Cancer. Annu Rev Med 60:167–179
7. Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376–385
8. Ha TY (2011) MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11:135–154
9. Gottardo F, Liu CG, Ferracin M et al (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25:387–392
10. Huang Y, Dai Y, Yang J et al (2009) Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol 35:1119–1123
11. Chow TF, Mankaruos M, Scorilas A et al (2010) The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol 183:743–751
12. Schaefer A, Stephan C, Busch J, Yousef GM, Jung K (2010) Diagnostic, prognostic and therapeutic implications of microR-NAs in urologic tumors. Nat Rev Urol 7:286–297
13. White NM, Yousef GM (2010) MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer. BMC Med 8:65
14. White NM, Bui A, Mejia-Guerrero S et al (2010) Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biol Chem 391:411–423
15. Zhou B, Wu H, Li W, Liu W, Luo D (2011) Microarray analysis of microRNA expression in skin of Xpc (+)/(-) mice and wild-type mice. Ir J Med Sci 180:721–726
16. Heinzelmann J, Henning B, Sanjmyatav J et al (2011) Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol 29:367–373
17. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T (2007) MicroRNA expression profiling in prostate cancer. Cancer Res 67:6130–6135
18. Ljungberg B (2007) Prognostic markers in renal cell carcinoma. Curr Opin Urol 17:303–308
19. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM (2010) The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 8:64
20. Saini S, Yamamura S, Majid S et al (2011) MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 71:6208–6219
21. ′-iod-othyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer. PLoS One 6:e24541
22. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114
23. Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–10518
24. Chim SS, Shing TK, Hung EC et al (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54:482–490
25. Hunter MP, Ismail N, Zhang X et al (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3:e3694
26. Zhu W, Liu X, He J, Chen D, Hunag Y, Zhang YK (2011) Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11:393
27. Liu J, Gao J, Du Y et al (2012) Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 131:683–691
28. Lakomy R, Sana J, Hankeova S et al (2011) MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 102:2186–2190